One Day Course: Data Integrity and Document Management for GxP Compliance (London, United Kingdom - September 27, 2019) - ResearchAndMarkets.com

The "Data Integrity and Document Management for GxP Compliance" conference has been added to ResearchAndMarkets.com's offering.

Data Integrity is a critical issue in document governance. It increasingly becoming a focus for regulatory inspections globally. This course will equip you with knowledge necessary to identify and avoid potential Data Integrity issues before auditors do.

Course Overview

Data integrity is now a focus for regulatory inspections, with both EU and FDA inspectors increasingly observing violations during GxP inspections. It has become a critical issue in document governance and regulators expect staff working in GxP roles to have been trained in this important area.

This concise course covers the background to data integrity, why it is important and how its requirements affect both paper-based and computer-based systems. The course will include discussion of the recently finalised MHRA data integrity guide which provides guidance on the data integrity expectations that should be considered by organisations involved in any aspect of the GxP pharmaceutical lifecycle (GCP, GMP, GLP and GvP). You will gain an understanding of the requirements for ensuring data integrity, review data integrity inspection findings, and get practical advice on defining and implementing an appropriate data governance process for compliance with data integrity requirements.

Benefits of attending:

• Understand the importance of data integrity and good document practice
• Discuss data integrity criteria and definitions - eg ALCOA
• Be aware of key regulations and guidelines
• Understand QMS considerations for data integrity and document management
• Review document management and data integrity inspections to facilitate regulatory compliance
• Consider the requirements for data integrity governance to prevent data integrity breaches

Who Should Attend:

This course is designed for managers and staff from all GxP areas in the pharmaceutical and medical device industries who are responsible for the creation, review, approval and/or reporting of data to ensure data integrity, in particular those working in:

• Clinical trials
• Manufacturing
• Quality assurance/quality control
• Compliance
• Pharmacovigilance

QA personnel from CROs/CMOs and GxP auditors responsible for carrying out audits and self-inspections or external audits will also benefit from the programme.

Agenda:

Principles of data integrity and good documentation practice

• What is data integrity?
• Why is data integrity important?
• ALCOA principles
• Good documentation practice including paper and electronic records

Data integrity regulations and guidelines

• MHRA/WHO/FDA/EMA/PICS/ICH GCP R2, Data Integrity guidelines
• Group review and discussion of some key regulated documents including the new MHRA data integrity guide

Document management and data integrity inspection findings

• MHRA, EMA findings, EU non-compliance reports
• FDA findings
• Group discussion on inspection findings

QMS considerations for Data integrity and documentation

• What are the elements of QMS for data integrity?
• Risk management considerations
• Data governance
• Discussion of participants experience and best practice for QMS and data governance

Data integrity for computer systems

• Computer system validation considerations
• What is expected for compliance for GXP systems

Discussion of document and data integrity issues

• Data integrity and digital signatures
• Certified copies/true copies
• TMF
• Managing and preventing data integrity breaches

Final questions and summary discussion

For more information about this conference visit https://www.researchandmarkets.com/r/blywal